Pharmaceutical Care of a Patient with Secondary Infection of Rhodococcus Equi and Aspergillus After Renal Transplantation
Objective To investigate the role of clinical pharmacists in drug treatment of patients with infections of Rhodococcus equi and Aspergillus after kidney transplantation.Methods Clinical pharmacists participated in the treatment of a patient with infection of Rhodococcus equi and Aspergillus after kidney transplantation,and implemented pharmaceutical care for the selection of anti-infective drugs and adverse drug reactions(ADRs).Results Based on the drug sensitivity test results of the patient and guidelines,the clinical pharmacist recommended a treatment plan.Due to the patient's long-term use of tacrolimus after kidney transplantation,the anti-infection plan was recommended to be adjusted to the combination of linezolid and erythromycin for the treatment of Rhodococcus equi,and cabozantine for the treatment of Aspergillus.Meanwhile,it was recommended to dynamically monitor platelet count and gastrointestinal reactions.The clinical physician adopted the advice of the clinical pharmacist,and the patient's infection indicators improved,and ADRs were effectively controlled.Conclusion Clinical pharmacists participating in pharmaceutical care of a patient with secondary infection of Rhodococcus Equi and Aspergillus after renal transplantation can improve the rational drug use,and ensure the medication safety of patients.
万方数据
维普
